“A Randomized Controlled Trial Comparing Vonoprazan and Proton Pump Inhibitors for Symptom Relief and Mucosal Healing in Scleroderma-Associated GERD”. 2025. Journal of Carcinogenesis 24 (8s): 542-46. https://doi.org/10.64149/J.Carcinog.24.8s.542-546.